CDK 4/6 Inhibitors in Metastatic Breast Cancer
1 Pogledi
administrator
07/03/23
Hope S. Rugo, MD, discusses the use of CDK 4/6 inhibitors and their impact on the treatment paradigm for metastatic breast cancer.
Prikaži više
Komentari na Facebooku
Nema komentara